Skip to main content
See all results

Science Stories

Making new and better medicines for patients is at the heart of what we do. They inspire us in our mission to create breakthrough therapies that change lives and they inspire us to lead the science and never give up. Every day our scientists are inspired to start new journeys of discovery that could lead to the next breakthrough. Find out more about those journeys through their science stories.

Latest Articles

Group of scientists from the Chemical Development department at Boehringer Ingelheim gathering in the kilolab facilities, where the first kilogram quantities of the drug substance is manufactured

Targeting MDM2-p53 in cancer: The story of Brigimadlin

Our perseverance and passion for science led to the discovery of Brigimadlin, our MDM2-p53 antagonist, that is being clinically investigated as a potential treatment for dedifferentiated liposarcoma, a rare cancer with significant unmet needs.

Read more
Lamine Mbow, Global Head of Cancer Immunology and Immune Modulation at Boehringer Ingelheim, shares our approach to Immuno-oncology
Science Stories

T-cell engagers: Reawakening T-cells to fight cancer

Lamine Mbow, our Global Head of Cancer Immunology and Immune Modulation, shares our approach to immuno-oncology, highlighting our T-cell engagers platform and how we are driving innovation to deliver meaningful advances to people with cancer.